Harnisha Dalwadi

Harnisha Dalwadi is an accomplished professional with extensive experience in medical writing and research. Harnisha has held positions at reputable companies such as Summit Therapeutics, Surrozen, Nektar Therapeutics, Pharmacyclics, Amgen, and MannKind Corporation. Harnisha has a strong background in leading and managing medical writing teams, ensuring the quality of clinical documents meets regulatory standards. Harnisha has a PhD in Pathology and Laboratory Medicine from UCLA and a BS in Molecular Biology from Rensselaer Polytechnic Institute. Throughout their career, Harnisha has demonstrated a commitment to excellence in their work and has been recognized with awards and nominations for their contributions.